Source: ProntoForms
  • ProntoForms Corporation’s (PFM) Fortune 500 medical device customer expands its ProntoForms implementation by 3500 subscriptions
  • The customer now has a total of over 9000 subscriptions globally
  • The recent expansion aides the installation and preventive maintenance of over 4000 medical devices
  • ProntoForms’ mobile and cloud integration, field service management systems and platforms creates a ‘best-of-breed’ solution
  • ProntoForms Corporation’s (PFM) is unchanged trading at $0.80 per share as of 3:10 p.m. EST

ProntoForms Corporation’s (PFM) Fortune 500 medical device customer has expanded its ProntoForms implementation by 3500 subscriptions.

The customer now has a total of over 9000 subscriptions globally to support asset installation and preventive maintenance services across multiple business units.

ProntoForms is a healthcare technology leader with over 30,000 employees across 100 countries and is a global leader in no-code app development platforms for field teams.

Before this expansion, the company already implemented ProntoForms’ solution throughout North America, EMEA, Latin America, and parts of APAC.

The recent expansion supports the installation and preventive maintenance of over 4000 medical devices, including MRIs.

ProntoForms’ mobile and cloud integration, field service management system, and customer relationship management platform creates a ‘best-of-breed’ solution.

Low-code tools enable the customer’s non-technical, business users to build and maintain ProntoForms for multiple product lines.

Alvaro Pombo, founder and CEO of ProntoForms, stated,

 “There were many product features and capabilities that came together in harmony for this expansion…  From collaboration features like ProntoForms Teamwork to our seamless integration with a leading field service management solution, this expansion highlights that our product is truly customizable and agile to the needs of different industries, geographies, and service types.”

ProntoForms’ Teamwork and Answer Exceptions platforms allow businesses to address the challenges of installing and maintaining complex medical assets.

This helps work that normally spans multiple days and requires the input of multiple engineers.

It also enables the effective assessment of hard and soft device failures.

ProntoForms Corporation’s (PFM) is unchanged trading at $0.80 per share as of 3:10 p.m. EST.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.